🕵️ Satellos Bioscience Inc. ($MSLE)
SEC insider & ownership activity, last 12 months · CIK 1421642 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. | 8.3% | 13G | May 12, 2026 | filing ↗ | |
| Qiming U.S. Healthcare GP III, LLC | 8.3% | 13G | May 12, 2026 | filing ↗ | |
| Mark McDade | 8.3% | 13G | May 12, 2026 | filing ↗ | |
| Gary E Rieschel | 8.3% | 13G | May 12, 2026 | filing ↗ | |
| Brian Matthew Bloom | 7.3% | 13G | May 15, 2026 | filing ↗ | |
| Bloom Burton & Co. Inc. | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Jolyon David Burton | 6.5% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.